Koninklijke Philips (PHG) Liabilities from Discontinued Operations (2010 - 2026)
Koninklijke Philips' (PHG) quarterly Liabilities from Discontinued Operations came in at 10536710.85 in Q1 2026, up 0.58% quarter-over-quarter from 10476391.63 in Q4 2025.
Koninklijke Philips (PHG) Liabilities from Discontinued Operations (2010 - 2026) Analysis & Trends
Koninklijke Philips' Liabilities from Discontinued Operations history runs 16 years deep, the most recent figure standing at 10536710.85 for Q1 2026.
- On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to 10536710.85 in Q1 2026; TTM through Mar 2026 was 10536710.85, a N/A change from a year earlier, with the FY2025 full-year figure at 10476391.63, changed N/A from the prior year.
- Liabilities from Discontinued Operations rose to 10536710.85 in Q1 2026 per PHG's latest filing, from 10476391.63 in the prior quarter.
- Across five years, Liabilities from Discontinued Operations topped out at 10536710.85 in Q1 2026 and bottomed at 1067056.69 in Q2 2022.
- The 5-year median for Liabilities from Discontinued Operations is 9683459.18 (2023), against an average of 8191656.23.
- Across the five-year window, Liabilities from Discontinued Operations plunged 99.89% in 2022 and soared 512.3% in 2023, its largest moves.
- Year by year, Liabilities from Discontinued Operations stood at 1067056.69 in 2022, then surged by 807.49% to 9683459.18 in 2023, then grew by 0.09% to 9691988.19 in 2024, then rose by 8.09% to 10476391.63 in 2025, then rose by 0.58% to 10536710.85 in 2026.
- Per Business Quant, the three latest PHG Liabilities from Discontinued Operations figures stand at 10536710.85 (Q1 2026), 10476391.63 (Q4 2025), and 9352440.73 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.54 Mn |
| Mar 31, 2026 | 10.54 Mn |
| Dec 31, 2025 | 10.48 Mn |
| Dec 31, 2025 | 10.48 Mn |
| Sep 30, 2025 | 9.35 Mn |
| Sep 30, 2025 | 9.35 Mn |
| Jun 30, 2024 | 9.69 Mn |
| Jun 30, 2024 | 9.69 Mn |
| Dec 31, 2023 | 9.68 Mn |
| Dec 31, 2023 | 9.68 Mn |
| Jun 30, 2023 | 6.53 Mn |
| Jun 30, 2023 | 6.53 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Dec 31, 2021 | 1.14 Mn |
| Dec 31, 2021 | 1.14 Mn |
| Jun 30, 2021 | 933.31 Mn |
| Jun 30, 2021 | 933.31 Mn |
| Dec 31, 2020 | 35.77 Mn |
| Dec 31, 2020 | 35.77 Mn |